NLS Pharmaceutics Ltd (NLSP)
0.1533
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.153
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
AC Immune SA | -26.96M |
CRISPR Therapeutics AG | -97.80M |
Addex Therapeutics Ltd | -0.0012M |
Molecular Partners AG | 21.20M |
MoonLake Immunotherapeutics | -28.80M |
Cash from Investing (Quarterly) Related Metrics
Free Cash Flow | -9.684M |
Free Cash Flow Yield | -154.7% |